Space Tango is a commercial space company focused on automated systems for research, development, and manufacturing in microgravity. They provide standardized platforms like CubeLabs and TangoLabs, primarily for use on the International Space Station (ISS) U.S. National Laboratory, enabling investigations in areas like cell culture, thin-film manufacturing, and protein-based artificial retinas. Through a NASA Space Act Agreement, Space Tango partners with organizations across various sectors, including pharmaceuticals and biotechnology, aiming to create valuable solutions for health and technology both in space and on Earth. Associated keywords include microgravity, ISS, CubeLabs, space manufacturing, and R&D.
All verified mentions of this organization in source documents.
Space Tango is developing a cloud-based platform to share data securely between B-SURE program participants.
Space Tango has supported over 200 automated research investigations on the International Space Station since 2017.
Space Tango contracted Sierra Space to provide Space Station Operational Modeling to determine the effectiveness of biomanufacturing using different alternative feedstocks.
Space Tango will collaborate with TERC and the Association of Space Explorers to expand the Windows on Earth audience and develop a global citizen science community.
Space Tango was named the official flight partner for the Windows on Earth platform on 2022-04-14.
Sierra Space and Space Tango are partnering to make manufacturing more accessible in space.
Sierra Space is leveraging Space Tango's experience in microgravity and automated systems to create additional market sectors.
The collaboration between Sierra Space and Space Tango is viewed as a step towards a new era for commercial space.
Space Tango's TangoLab facilities and TangoBox will be used to reduce the cost of accessing space.
The collaboration between Sierra Space and Space Tango is expected to open new market opportunities in low-Earth orbit (LEO).
Sierra Space and Space Tango signed a memorandum of understanding (MOU) to explore microgravity for new commercial opportunities.
Space Tango will make its portfolio of automated facilities available to Sierra Space customers, including NASA.
Space Tango launched an initial mission with LambdaVision to evaluate protein-based retinal implant production on orbit on the SpaceX Commercial Resupply Services-16 (CRS-16) mission from Cape Canaveral, Florida on 2018-12-05 at approximately 1:16 PM EST.
Space Tango is developing ST-42, a fully autonomous robotic orbital platform designed specifically for scalable manufacturing in low Earth orbit.
On 2018-11-15, Space Tango plans to launch in the mid-2020s an autonomous in-orbit manufacturing facility called ST-42.
Space Tango plans to build multiple versions of ST-42 with a consistent exterior design and interiors adapted for specific applications.
Space Tango has sent 53 payloads with a total of 88 experiments into orbit for customers including Budweiser, The Quest Institute for Quality Education, and Airbus Defense and Space.
Space Tango intends to incorporate Current Good Manufacturing Practice features into ST-42’s initial design to support on-orbit production of patient therapeutics.
Space Tango is working with LambdaVision, a Farmington, Connecticut company, to test whether LambdaVision can produce retinal implants in microgravity.
Space Tango develops products and processes to streamline research, operation of experiments, and manufacturing in microgravity on the International Space Station to improve life on Earth.